Azenta, Inc. Logo

Azenta, Inc.

Life science solutions for pharma & biotech, offering sample management, storage & multiomics.

AZTA | NDAQ

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
United States of America
Address:
200 SUMMIT DRIVE, 1803 BURLINGTON
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Azenta, Inc. is a global provider of integrated life sciences solutions designed to accelerate the discovery, development, and delivery of new therapies. The company's portfolio centers on sample lifecycle management, offering a comprehensive suite of products and services that includes automated ultra-cold and cryogenic storage systems, consumables, and informatics software for sample management. Through its GENEWIZ brand, Azenta also provides extensive multiomics and synthesis services, such as next-generation sequencing, Sanger sequencing, and gene synthesis. Serving clients in the pharmaceutical, biotechnology, and academic sectors, Azenta supports critical workflows from research and clinical trials to manufacturing, enabling organizations to bring impactful breakthroughs to market faster.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Azenta, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Azenta, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Azenta, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Cantargia Logo
Develops antibody treatments targeting IL1RAP for cancer and autoimmune/inflammatory diseases.
Sweden CANTA
Captor Therapeutics S.A. Logo
Developing TPD therapeutics for oncology and autoimmune diseases with its Optigrade™ platform.
Poland CTX
Cardiff Oncology, Inc. Logo
Clinical-stage biotech developing a PLK1 inhibitor to treat resistant cancers.
United States of America CRDF
Cardio Diagnostics Holdings, Inc. Logo
AI-powered epigenetic and genetic tests for early detection of heart disease risk.
United States of America CDIO
Cardiol Therapeutics Inc. Logo
Develops oral cannabidiol therapies for inflammatory and fibrotic heart diseases.
United States of America CRDL
CareDx, Inc. Logo
Precision diagnostics and surveillance solutions for the organ transplant journey.
United States of America CDNA
Offers one-stop BPO, CRM, and staffing for admin, manufacturing, and logistics.
Japan 6070
Caris Life Sciences, Inc. Logo
Pioneering precision cancer care via AI-powered molecular profiling and diagnostics.
United States of America CAI
Carna Biosciences, Inc. Logo
Develops kinase inhibitor drugs for oncology/autoimmune diseases & offers discovery support services.
Japan 4572
CARTA HOLDINGS, INC. Logo
Digital marketing firm offering ad platforms and integrated solutions to empower businesses.
Japan 3688

Talk to a Data Expert

Have a question? We'll get back to you promptly.